Charles Bramlage
Chief Executive Officer at Yamo Pharmaceuticals LLC
Profile
Charles J.
Bramlage currently works at Yamo Pharmaceuticals LLC, as Chief Executive Officer and Clarametyx Biosciences, Inc., as Director.
Mr. Bramlage also formerly worked at Ventaira Pharmaceuticals, Inc., as President & Chief Executive Officer from 2001 to 2004, Pearl Therapeutics, Inc., as President, Chief Executive Officer & Director from 2011 to 2016, BioDelivery Sciences International, Inc., as Independent Director from 2014 to 2017, Locus Biosciences, Inc., as Director, Eiger BioPharmaceuticals, Inc., as Independent Director from 2016 to 2018, Bausch Health Americas, Inc., as President-North America & EMEA from 2003 to 2008, Merck & Co., Inc., as Principal, GSK Plc, as VP-Respiratory Global Commercial Development from 1983 to 2001, and Covidien Unlimited Co., as President-Pharmaceutical Products from 2008 to 2011.
Mr. Bramlage received his Masters Business Admin degree from the University of Dayton and undergraduate degree from Fisher College of Business.
Charles Bramlage active positions
| Companies | Position | Start |
|---|---|---|
Clarametyx Biosciences, Inc.
 Clarametyx Biosciences, Inc. BiotechnologyHealth Technology Clarametyx Biosciences, Inc. operates as a biotechnology company. It develops a dynamic pipeline of immune-enabling therapies and vaccines for chronic and recurrent bacterial infections. The company was founded by Michael Triplett, Peter G. Kleinhenz, Juliana Woda, and Charles McOsker and is headquartered in Columbus, OH. | Director/Board Member | - |
Yamo Pharmaceuticals LLC
 Yamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Yamo Pharmaceuticals LLC is a clinical stage pharmaceutical company that was founded in 2015. Yamo Pharmaceuticals is a privately held company and is based in New York, NY. The company's focus is on developing L1-79, a novel therapy that has the potential to improve the core symptoms of ASD. The CEO of the company is Charles J. Bramlage. | Chief Executive Officer | - |
Former positions of Charles Bramlage
| Companies | Position | End |
|---|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Director/Board Member | 2018-01-03 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Director/Board Member | 2017-12-06 |
Pearl Therapeutics, Inc.
 Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Chief Executive Officer | 2016-10-31 |
Covidien Unlimited Co.
 Covidien Unlimited Co. Medical SpecialtiesHealth Technology Covidien Unlimited Co. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. It operates through Medical Devices and U.S. Medical Supplies segments. The Medical Devices segment involves in the distribution of surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. The U.S. Medical Supplies segment includes marketing of nursing care, medical surgical, SharpSafety brand, and original equipment manufacturer (OEM) products. The company was founded in 1967 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | 2010-12-31 |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 2008-06-30 |
Training of Charles Bramlage
| University of Dayton | Masters Business Admin |
| Fisher College of Business | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GSK PLC | Health Technology |
| MERCK & CO., INC. | Health Technology |
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Health Technology |
Ventaira Pharmaceuticals, Inc.
 Ventaira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ventaira Pharmaceuticals Inc. develops aerosol devices. It offers inhaled drugs, including fentanyl for the treatment of breakthrough pain and salmeterol/flucticasone for asthma. The company was founded in April 2000 and is headquartered in Columbus, OH. | Health Technology |
Covidien Unlimited Co.
Covidien Unlimited Co. Medical SpecialtiesHealth Technology Covidien Unlimited Co. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. It operates through Medical Devices and U.S. Medical Supplies segments. The Medical Devices segment involves in the distribution of surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. The U.S. Medical Supplies segment includes marketing of nursing care, medical surgical, SharpSafety brand, and original equipment manufacturer (OEM) products. The company was founded in 1967 and is headquartered in Dublin, Ireland. | Health Technology |
Pearl Therapeutics, Inc.
Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Locus Biosciences, Inc.
 Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Technology Services |
Clarametyx Biosciences, Inc.
Clarametyx Biosciences, Inc. BiotechnologyHealth Technology Clarametyx Biosciences, Inc. operates as a biotechnology company. It develops a dynamic pipeline of immune-enabling therapies and vaccines for chronic and recurrent bacterial infections. The company was founded by Michael Triplett, Peter G. Kleinhenz, Juliana Woda, and Charles McOsker and is headquartered in Columbus, OH. | Health Technology |
Yamo Pharmaceuticals LLC
Yamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Yamo Pharmaceuticals LLC is a clinical stage pharmaceutical company that was founded in 2015. Yamo Pharmaceuticals is a privately held company and is based in New York, NY. The company's focus is on developing L1-79, a novel therapy that has the potential to improve the core symptoms of ASD. The CEO of the company is Charles J. Bramlage. | Health Technology |
- Stock Market
- Insiders
- Charles Bramlage
